117 related articles for article (PubMed ID: 9396697)
1. Diversity of lipopolysaccharide structures in Campylobacter jejuni.
Penner JL; Aspinall GO
J Infect Dis; 1997 Dec; 176 Suppl 2():S135-8. PubMed ID: 9396697
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure.
Aspinall GO; Fujimoto S; McDonald AG; Pang H; Kurjanczyk LA; Penner JL
Infect Immun; 1994 May; 62(5):2122-5. PubMed ID: 8168981
[TBL] [Abstract][Full Text] [Related]
3. Structure and conserved characteristics of Campylobacter jejuni lipopolysaccharides.
Moran AP
J Infect Dis; 1997 Dec; 176 Suppl 2():S115-21. PubMed ID: 9396693
[TBL] [Abstract][Full Text] [Related]
4. Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3.
Salloway S; Mermel LA; Seamans M; Aspinall GO; Nam Shin JE; Kurjanczyk LA; Penner JL
Infect Immun; 1996 Aug; 64(8):2945-9. PubMed ID: 8757818
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of O antigen chains from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome.
Aspinall GO; McDonald AG; Pang H
Biochemistry; 1994 Jan; 33(1):250-5. PubMed ID: 7506928
[TBL] [Abstract][Full Text] [Related]
6. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
Yuki N
J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
[TBL] [Abstract][Full Text] [Related]
7. Lipo-oligosaccharides of Campylobacter jejuni serotype O:10. Structures of core oligosaccharide regions from a bacterial isolate from a patient with the Miller-Fisher syndrome and from the serotype reference strain.
Shin JE; Ackloo S; Mainkar AS; Monteiro MA; Pang H; Penner JL; Aspinall GO
Carbohydr Res; 1997 Dec; 305(2):223-32. PubMed ID: 9581276
[TBL] [Abstract][Full Text] [Related]
8. Characterization of two Campylobacter jejuni strains for use in volunteer experimental-infection studies.
Poly F; Read TD; Chen YH; Monteiro MA; Serichantalergs O; Pootong P; Bodhidatta L; Mason CJ; Rockabrand D; Baqar S; Porter CK; Tribble D; Darsley M; Guerry P
Infect Immun; 2008 Dec; 76(12):5655-67. PubMed ID: 18809665
[TBL] [Abstract][Full Text] [Related]
9. Chemical structure of the core oligosaccharide of aerotolerant Campylobacter jejuni O:2 lipopolysaccharide.
Hanniffy OM; Shashkov AS; Moran AP; Senchenkova SN; Savage AV
Carbohydr Res; 2001 Jan; 330(2):223-9. PubMed ID: 11217975
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome.
Aspinall GO; McDonald AG; Pang H; Kurjanczyk LA; Penner JL
Biochemistry; 1994 Jan; 33(1):241-9. PubMed ID: 8286348
[TBL] [Abstract][Full Text] [Related]
11. Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner.
Bax M; Kuijf ML; Heikema AP; van Rijs W; Bruijns SC; García-Vallejo JJ; Crocker PR; Jacobs BC; van Vliet SJ; van Kooyk Y
Infect Immun; 2011 Jul; 79(7):2681-9. PubMed ID: 21502591
[TBL] [Abstract][Full Text] [Related]
12. Serological diversity and chemical structures of Campylobacter jejuni low-molecular-weight lipopolysaccharides.
Aspinall GO; McDonald AG; Raju TS; Pang H; Mills SD; Kurjanczyk LA; Penner JL
J Bacteriol; 1992 Feb; 174(4):1324-32. PubMed ID: 1370951
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome.
Jacobs BC; Hazenberg MP; van Doorn PA; Endtz HP; van der Meché FG
J Infect Dis; 1997 Mar; 175(3):729-33. PubMed ID: 9041356
[TBL] [Abstract][Full Text] [Related]
14. Molecular mimicry in Campylobacter jejuni lipopolysaccharides and the development of Guillain-Barré syndrome.
Moran AP; Prendergast MM
J Infect Dis; 1998 Nov; 178(5):1549-51. PubMed ID: 9780289
[No Abstract] [Full Text] [Related]
15. Demonstration of lipopolysaccharide with O-polysaccharide chains among different heat-stable serotypes of Campylobacter jejuni by silver staining of polyacrylamide gels.
Blake DC; Russell RG
Infect Immun; 1993 Dec; 61(12):5384-7. PubMed ID: 7693600
[TBL] [Abstract][Full Text] [Related]
16. Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides.
Aspinall GO; McDonald AG; Raju TS; Pang H; Moran AP; Penner JL
Eur J Biochem; 1993 May; 213(3):1017-27. PubMed ID: 8240486
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
Prendergast MM; Moran AP
J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
[TBL] [Abstract][Full Text] [Related]
18. Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes.
Houliston RS; Yuki N; Hirama T; Khieu NH; Brisson JR; Gilbert M; Jarrell HC
Biochemistry; 2007 Jan; 46(1):36-44. PubMed ID: 17198373
[TBL] [Abstract][Full Text] [Related]
19. Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity.
Moran AP; Prendergast MM
J Autoimmun; 2001 May; 16(3):241-56. PubMed ID: 11334489
[TBL] [Abstract][Full Text] [Related]
20. [Immunopathological evidence of terminal residues containing sialic acid in Campylobacter jejuni lipopolysaccharide as the critical antigen to induce peripheral neuropathy].
Xiang SL; Cai FC; Zhang XP; Deng B
Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):665-70. PubMed ID: 16191299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
